Say Hello Kybella, Goodbye Double Chin!

I am pleased to introduce Kybella™ — the first NON-INVASIVE, FDA-approved injectable for treatment of that dreaded "double chin" (also known as submental fat).  As a member of the Speakers Bureau for Kybella, I'm posting this from Chicago, where I was invited as the chosen plastic surgeon from Massachusetts to participate as a physician trainer for clinical instruction and education.What makes this new offering so exciting is that after a treatment plan of usually 6 or fewer sessions, your double-chin problems are over. This is a permanent destruction of fat cells. It was written about recently in the New York Times. My practice will be one of the few offering this new treatment in Massachusetts.How it works.The active ingredient in Kybella is deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath your chin, it causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.  See also: FDA approves treatment for fat below the chin. Link to our Kybella page: Kybella Now Offered on Boston's South Shore!Call now to book a consult to evaluate if you are a candidate for Kybella! at (781) 934-2200.Christine Hamori Cosmetic Surgery + Skin Spa95 Tremont Street, Suite 28, Duxbury, Massachusetts, 02332Call us: 781-934-2200Serving Boston's South Shore, Cape Cod and NantucketChristine Hamori Cosmetic Surgery + Skin Spa 95 Tremo...
Source: What's New In Plastic Surgery? - Category: Cosmetic Surgery Tags: boston double chin kybella submental fat Source Type: blogs

Related Links:

CONCLUSIONS: If there is a causal association between DMPA use and HIV risk, it could have substantially increased the scale of the HIV epidemic in South Africa, affecting not only the users of DMPA, but also their partners and the wider population. The magnitude of this potential effect demands careful data collection and a careful consideration of policy choices for contraception in settings with large HIV epidemics. PMID: 31729195 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
CONCLUSIONS: The prevalence of HIV among transgender women in our study, at 14.8%, is among the highest detected in any population in eastern China. Chinese transgender women may therefore follow the disparity in the burden of HIV noted worldwide. Data support policies to prioritize transgender women for HIV testing outreach, for in-depth research to better understand the specific drivers of infection in this population, and for trans-friendly HIV care and prevention programmes to address their specific needs. PMID: 31729178 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
Government officials say the objective is to encourage competition and reduce costs
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
Studies have linked hearing loss to brain health and memory issues.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
Authors: Araujo-Mariz C, Militão de Albuquerque MFP, Lopes EP, Ximenes RAA, Lacerda HR, Miranda-Filho DB, Lustosa-Martins BB, Pastor AFP, Acioli-Santos B Abstract INTRODUCTION AND OBJECTIVE: Hepatotoxicity during tuberculosis (TB) treatment is frequent and may be related to the Arylamine N-Acetyltransferase (NAT2) acetylator profile, in which allele frequencies differ according to the population. The aim of this study was to investigate functional polymorphisms in NAT2 associated with the development of hepatotoxicity after initiating treatment for TB in people living with HIV/AIDS (PLWHA) in Pernambuco, Nor...
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Alternative Medicine, News, Source Type: news
Dose reductions of lamivudine may not be necessary for all patients with mild to moderate renal impairment, says Dr Paul Sax.Medscape HIV/AIDS
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS Commentary Source Type: news
Condition:   HIV/AIDS Interventions:   Behavioral: PrEP campaign messages developed via open contest;   Behavioral: PrEP campaign messages developed via social marketing approach Sponsor:   Johns Hopkins Bloomberg School of Public Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Hepatitis D, Chronic;   Hepatitis B, Chronic Intervention:   Sponsor:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Abstract There is a wide variety of causes of diffuse lung disease in the intensive care unit patient, of which adult respiratory distress syndrome is the commonest clinical consideration. Plain radiography, computed tomography, and ultrasound can be used synergistically to evaluate patients with diffuse lung disease and respiratory impairment. Imaging is not limited to characterization of the cause of diffuse lung disease but also aids in monitoring its evolution and in ventilator setting management. PMID: 31731896 [PubMed - in process]
Source: Radiologic Clinics of North America - Category: Radiology Authors: Tags: Radiol Clin North Am Source Type: research
More News: Education | HIV AIDS | Nutrition | Plastic Surgeons | Plastic Surgery | Skin | Universities & Medical Training